Vitamin D for COVID-19
8th treatment shown to reduce risk in
October 2020
Lower risk for mortality, ICU admission, hospitalization, progression, recovery, cases, and viral clearance.
No treatment is 100% effective. Protocols
combine complementary and synergistic treatments. * >10%
efficacy in meta analysis with ≥3 clinical studies.
4,100+ studies for
60+ treatments. c19early.org
|
risk of severe case, 59.7% lower, RR 0.40, p = 0.13, high D levels (≥20ng/ml) 7 of 59 (11.9%), low D levels (<20ng/ml) 5 of 17 (29.4%), NNT 5.7, deficiency vs. other.
|
risk of case, 89.0% lower, OR 0.11, p = 0.13, high D levels (≥20ng/ml) 59 of 76 (77.6%) cases,
15 of 15 (100.0%) controls, NNT 4.9, case control OR.
|
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates |